{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:31:53Z","timestamp":1770823913000,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1007\/s11912-004-0063-9","type":"journal-article","created":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T16:34:05Z","timestamp":1180715645000},"page":"369-379","source":"Crossref","is-referenced-by-count":1,"title":["Molecular diagnosis in lymphoma"],"prefix":"10.1007","volume":"6","author":[{"given":"Adam","family":"Bagg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"63_CR1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00062752-200207000-00011","volume":"9","author":"RE Davis","year":"2002","unstructured":"Davis RE, Staudt LM: Molecular diagnosis of lymphoid malignancies by gene expression profiling. Curr Opin Hematol 2002, 9:333\u2013338.","journal-title":"Curr Opin Hematol"},{"key":"63_CR2","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1056\/NEJMra020067","volume":"348","author":"LM Staudt","year":"2003","unstructured":"Staudt LM: Molecular diagnosis of the hematologic cancers. N Engl J Med 2003, 348:1777\u20131785. Informative, concise, and contemporary overview of recent microarray studies in leukemia and lymphoma. 3. Bagg A: Clinical applications of molecular genetic testing in hematologic malignancies: advantages and limitations. Hum Pathol 2003, 34:352-358.","journal-title":"N Engl J Med"},{"key":"63_CR3","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/sj.leu.2402922","volume":"17","author":"VH Velden van der","year":"2003","unstructured":"van der Velden VH, Hochhaus A, Cazzaniga G, et al.: Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects. Leukemia 2003, 17:1013\u20131034. Most useful resource for the development of clinically relevant realtime PCR assays.","journal-title":"Leukemia"},{"key":"63_CR4","first-page":"373","volume":"36","author":"EA Macintyre","year":"1999","unstructured":"Macintyre EA, Delabasse E: Molecular approaches to the diagnosis and evaluation of lymphoid malignancies. Semin Hematol 1999, 36:373\u2013389.","journal-title":"Semin Hematol"},{"key":"63_CR5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1525-1578(10)60685-X","volume":"4","author":"A Bagg","year":"2002","unstructured":"Bagg A, Braziel RM, Arber DA, et al.: Immunoglobulin heavy chain gene analysis in lymphomas: a multi-center study demonstrating the heterogeneity of performance of polymerase chain reaction assays. J Mol Diagn 2002, 4:81\u201389.","journal-title":"J Mol Diagn"},{"key":"63_CR6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1586\/14737159.1.2.191","volume":"1","author":"B Gleissner","year":"2001","unstructured":"Gleissner B, Thiel E: Detection of immunoglobulin heavy chain gene rearrangements in hematologic malignancies. Expert Rev Mol Diag 2001, 1:191\u2013200.","journal-title":"Expert Rev Mol Diag"},{"key":"63_CR7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1525-1578(10)60664-2","volume":"3","author":"DA Arber","year":"2001","unstructured":"Arber DA, Braziel RM, Bagg A, et al.: Evaluation of T cell receptor testing in lymphoid neoplasms: results of a multicenter study of 29 extracted DNA and paraffin-embedded samples. J Mol Diagn 2001, 3:133\u2013140.","journal-title":"J Mol Diagn"},{"key":"63_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jcp.56.1.1","volume":"56","author":"E Hodges","year":"2003","unstructured":"Hodges E, Krishna MT, Pickard C, Smith JL: Diagnostic role of tests for T cell receptor (TCR) genes. J Clin Pathol 2003, 56:1\u201311.","journal-title":"J Clin Pathol"},{"key":"63_CR9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1525-1578(10)60694-0","volume":"4","author":"TC Greiner","year":"2002","unstructured":"Greiner TC, Rubocki RJ: Effectiveness of capillary electrophoresis using fluorescent-labeled primers in detecting T-cell receptor gamma gene rearrangements. J Mol Diagn 2002, 4:137\u2013143.","journal-title":"J Mol Diagn"},{"key":"63_CR10","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0002-9440(10)64897-3","volume":"160","author":"JC Aster","year":"2002","unstructured":"Aster JC, Longtine JA: Detection of BCL2 rearrangements in follicular lymphoma. Am J Pathol 2002, 160:759\u2013763.","journal-title":"Am J Pathol"},{"key":"63_CR11","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0002-9440(10)64905-X","volume":"160","author":"A Albinger-Hegyi","year":"2002","unstructured":"Albinger-Hegyi A, Hochreutener B, Abdou MT, et al.: High frequency of t(14, 18)-translocation breakpoints outside of major breakpoint and minor cluster regions in follicular lymphomas: improved polymerase chain reaction protocols for their detection. Am J Pathol 2002, 160:823\u2013832.","journal-title":"Am J Pathol"},{"key":"63_CR12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1053\/beha.2002.0191","volume":"15","author":"JG Gribben","year":"2002","unstructured":"Gribben JG: Monitoring disease in lymphoma and CLL patients using molecular techniques. Best Pract Res Clin Haematol 2002, 15:179\u201395.","journal-title":"Best Pract Res Clin Haematol"},{"issue":"Suppl 1","key":"63_CR13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/annonc\/11.suppl_1.S137","volume":"11","author":"A Lopez-Guillermo","year":"2000","unstructured":"Lopez-Guillermo A, Cabanillas F, McLaughlin P, et al.: Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma: update of the MDACC series. Ann Oncol 2000, 11(Suppl 1):137\u2013140.","journal-title":"Ann Oncol"},{"key":"63_CR14","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1046\/j.1365-2141.2003.04086.x","volume":"120","author":"DE Horsman","year":"2003","unstructured":"Horsman DE, Okamoto I, Ludkovski O, et al.: Follicular lymphoma lacking the t(14, 18)(q32, q21): identification of two disease subtypes. Br J Haematol 2003, 120:424\u2013433.","journal-title":"Br J Haematol"},{"key":"63_CR15","first-page":"2133","volume":"9","author":"SL Barrans","year":"2003","unstructured":"Barrans SL, Evans PA, O\u2019Connor SJ, et al.: The t(14, 18) is associated with germinal center-derived diffuse large B-cell lymphoma and is a strong predictor of outcome. Clin Cancer Res 2003, 9:2133\u20132139.","journal-title":"Clin Cancer Res"},{"key":"63_CR16","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1046\/j.1365-2141.2002.03435.x","volume":"117","author":"SL Barrans","year":"2002","unstructured":"Barrans SL, O\u2019Connor SJ, Evans PA, et al.: Rearrangement of the BCL6 locus at 3q27 is an independent poor prognostic factor in nodal diffuse large B-cell lymphoma. Br J Haematol 2002, 117:322\u2013332.","journal-title":"Br J Haematol"},{"key":"63_CR17","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh AA, Eisen MB, Davis RE, et al.: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403:503\u2013511. First and paradigmatic microarray study in hematologic malignancies.","journal-title":"Nature"},{"key":"63_CR18","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","volume":"346","author":"A Rosenwald","year":"2002","unstructured":"Rosenwald A, Wright G, Chan WC, et al.: The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002, 346:1937\u20131947.","journal-title":"N Engl J Med"},{"key":"63_CR19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC, et al.: Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004, 103:275\u2013282. Validation of simply performed immunohistochemical assays to delineate clinically relevant histogenic groups of diffuse large B-cell lymphoma.","journal-title":"Blood"},{"key":"63_CR20","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1749-6632.2003.tb06073.x","volume":"987","author":"L Pasqualucci","year":"2003","unstructured":"Pasqualucci L, Migliazza A, Ye BH, Dalla-Favera R: Transcriptional deregulation of mutated BCL6 alleles by loss of negative autoregulation in diffuse large B cell lymphoma. Ann N Y Acad Sci 2003, 987:314\u2013315.","journal-title":"Ann N Y Acad Sci"},{"key":"63_CR21","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1182\/blood.V98.4.945","volume":"98","author":"IS Lossos","year":"2001","unstructured":"Lossos IS, Jones CD, Warnke R, et al.: Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. Blood 2001, 98:945\u2013951.","journal-title":"Blood"},{"key":"63_CR22","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1046\/j.1365-2141.2003.04761.x","volume":"124","author":"F Bertoni","year":"2004","unstructured":"Bertoni F, Zucca E, Cotter FE: Molecular basis of mantle cell lymphoma. Br J Haematol 2004, 124:130\u2013140.","journal-title":"Br J Haematol"},{"key":"63_CR23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1525-1578(10)60704-0","volume":"4","author":"VA Thomazy","year":"2002","unstructured":"Thomazy VA, Luthra R, Uthman MO, et al.: Determination of cyclin D1 and CD20 mRNA levels by real-time quantitative RT-PCR from archival tissue sections of mantle cell lymphoma and other non-Hodgkin\u2019s lymphomas. J Mol Diagn 2002, 4:201\u2013208.","journal-title":"J Mol Diagn"},{"key":"63_CR24","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1080\/1042819031000079168","volume":"44","author":"P Hui","year":"2003","unstructured":"Hui P, Howe JG, Crouch J, et al.: Real-time quantitative RTPCR of cyclin D1 mRNA in mantle cell lymphoma: comparison with FISH and immunohistochemistry. Leuk Lymphoma 2003, 44:1385\u20131394.","journal-title":"Leuk Lymphoma"},{"key":"63_CR25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","volume":"3","author":"A Rosenwald","year":"2003","unstructured":"Rosenwald A, Wright G, Wiestner A, et al.: The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 2003, 3:185\u201397.","journal-title":"Cancer Cell"},{"key":"63_CR26","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1073\/pnas.0831102100","volume":"100","author":"NY Fang","year":"2003","unstructured":"Fang NY, Greiner TC, Weisenburger DD, et al.: Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma. Proc Natl Acad Sci U S A 2003, 100:5372\u20135377.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"63_CR27","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1182\/blood.V93.11.3601","volume":"93","author":"J Dierlamm","year":"1999","unstructured":"Dierlamm J, Baens M, Wlodarska I, et al.: The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11, 18)(q21, q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 1999, 93:3601\u20133609.","journal-title":"Blood"},{"key":"63_CR28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(00)03571-6","volume":"357","author":"H Liu","year":"2001","unstructured":"Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A, et al.: Resistance of t(11, 18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet 2001, 357:39\u201340. Documentation of the therapeutic relevance of molecular testing in gastric MALT lymphoma.","journal-title":"Lancet"},{"key":"63_CR29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1365-2559.2002.01360.x","volume":"40","author":"B Maes","year":"2002","unstructured":"Maes B, De Wolf-Peeters C: Marginal zone cell lymphoma: an update on recent advances. Histopathology 2002, 40:117\u2013126.","journal-title":"Histopathology"},{"key":"63_CR30","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1182\/blood.V98.4.1182","volume":"98","author":"H Liu","year":"2001","unstructured":"Liu H, Ye H, Dogan A, et al.: T(11, 18)(q21, q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood 2001, 98:1182\u20131187.","journal-title":"Blood"},{"key":"63_CR31","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1182\/blood-2002-09-2963","volume":"101","author":"B Streubel","year":"2003","unstructured":"Streubel B, Lamprecht A, Dierlamm J, et al.: t(14, 18)(q32, q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood 2003, 101:2335\u20132339.","journal-title":"Blood"},{"key":"63_CR32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V99.1.3","volume":"99","author":"P Starostik","year":"2002","unstructured":"Starostik P, Patzner J, Greiner A, et al.: Gastric marginal zone Bcell lymphomas of MALT type develop along 2 distinct pathogenetic pathways. Blood 2002, 99:3\u20139.","journal-title":"Blood"},{"key":"63_CR33","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/sj.leu.2402537","volume":"16","author":"S Stilgenbauer","year":"2002","unstructured":"Stilgenbauer S, Bullinger L, Lichter P, et al.: Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course. Leukemia 2002, 16:993\u20131007. Insightful review of the genetic abnormalities in chronic lymphocytic leukemia.","journal-title":"Leukemia"},{"key":"63_CR34","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0740-2570(03)00012-1","volume":"20","author":"A Dogan","year":"2003","unstructured":"Dogan A, Isaacson PG: Splenic marginal zone lymphoma. Semin Diagn Pathol 2003, 20:121\u2013127.","journal-title":"Semin Diagn Pathol"},{"key":"63_CR35","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/sj.leu.2402528","volume":"16","author":"MJ Dyer","year":"2002","unstructured":"Dyer MJ, Oscier DG: The configuration of the immunoglobulin genes in B cell chronic lymphocytic leukemia. Leukemia 2002, 16:973\u2013984.","journal-title":"Leukemia"},{"key":"63_CR36","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1182\/blood-2002-10-3306","volume":"101","author":"A Wiestner","year":"2003","unstructured":"Wiestner A, Rosenwald A, Barry TS, et al.: ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 2003, 101:4944\u20134951.","journal-title":"Blood"},{"key":"63_CR37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0140-6736(03)15260-9","volume":"363","author":"JA Orchard","year":"2004","unstructured":"Orchard JA, Ibbotson RE, Davis Z, et al.: ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet 2004, 363:105\u2013111.","journal-title":"Lancet"},{"key":"63_CR38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1470-2045(03)01319-6","volume":"5","author":"RK Thomas","year":"2004","unstructured":"Thomas RK, Re D, Wolf J, Diehl V, Part I: Hodgkin\u2019s lymphoma: molecular biology of Hodgkin and Reed-Sternberg cells. Lancet Oncol 2004, 5:11\u201318. Current summary of insights into the molecular pathogenesis of Hodgkin lymphoma.","journal-title":"Lancet Oncol"},{"key":"63_CR39","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/jcp.56.3.188","volume":"56","author":"C Bellan","year":"2003","unstructured":"Bellan C, Lazzi S, De Falco G, et al.: Burkitt\u2019s lymphoma: new insights into molecular pathogenesis. J Clin Pathol 2003, 56:188\u2013192.","journal-title":"J Clin Pathol"},{"key":"63_CR40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1046\/j.1365-2141.2003.04238.x","volume":"121","author":"F Haralambieva","year":"2003","unstructured":"Haralambieva F, Banham AH, Bastard C, et al.: Detection by the fluorescence in situ hybridization technique of MYC translocation in paraffin-embedded lymphoma biopsy samples. Br J Haematol 2003, 121:49\u201356.","journal-title":"Br J Haematol"},{"key":"63_CR41","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1182\/blood.V100.8.2996","volume":"100","author":"RF Schop","year":"2002","unstructured":"Schop RF, Kuehl WM, Van Wier SA, et al.: Waldenstrom macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocation but have frequent 6q deletions. Blood 2002, 100:2996\u20133001.","journal-title":"Blood"},{"key":"63_CR42","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1365-2141.2001.02574.x","volume":"113","author":"SW Morris","year":"2001","unstructured":"Morris SW, Xue L, Ma Z, Kinney MC: Alk+ CD30+ lymphomas: a distinct molecular genetic subtype of non-Hodgkin\u2019s lymphoma. Br J Haematol 2001, 113:275\u2013295.","journal-title":"Br J Haematol"},{"key":"63_CR43","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1097\/00000478-199911000-00009","volume":"23","author":"KA Cataldo","year":"1999","unstructured":"Cataldo KA, Jalal SM, Law ME, et al.: Detection of t(2, 5) in anaplastic large cell lymphoma: comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue. Am J Surg Pathol 1999, 23:1386\u20131392.","journal-title":"Am J Surg Pathol"},{"key":"63_CR44","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1182\/blood-2003-03-0786","volume":"102","author":"RD Gascoyne","year":"2003","unstructured":"Gascoyne RD, Lamant L, Martin-Subero JI, et al.: ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases. Blood 2003, 102:2568\u20132573.","journal-title":"Blood"},{"key":"63_CR45","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/01.MP.0000026615.04130.1F","volume":"15","author":"MH Cessna","year":"2002","unstructured":"Cessna MH, Zhou H, Sanger WG, et al.: Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases. Mod Pathol 2002, 15:931\u2013938.","journal-title":"Mod Pathol"},{"key":"63_CR46","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0002-9440(10)64441-0","volume":"161","author":"A Zettl","year":"2002","unstructured":"Zettl A, Ott G, Makulik A, et al.: Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma. Am J Pathol 2002, 161:1635\u20131645.","journal-title":"Am J Pathol"},{"key":"63_CR47","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2003-05-1675","volume":"102","author":"K Belhadj","year":"2003","unstructured":"Belhadj K, Reyes F, Farcet JP, et al.: Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood 2003, 102:4261\u20134269.","journal-title":"Blood"},{"key":"63_CR48","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S1525-1578(10)60622-8","volume":"2","author":"KS Elenitoba-Johnson","year":"2000","unstructured":"Elenitoba-Johnson KS, Bohling SD, Mitchell RS, et al.: PCR analysis of the immunoglobulin heavy chain gene in polyclonal processes can yield pseudoclonal bands as an artifact of low B cell number. J Mol Diagn 2000, 2:92\u201396.","journal-title":"J Mol Diagn"},{"key":"63_CR49","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s00277-002-0427-x","volume":"81","author":"J Basecke","year":"2002","unstructured":"Basecke J, Griesinger F, Trumper L, Brittinger G: Leukemia- and lymphoma-associated genetic aberrations in healthy individuals. Ann Hematol 2002, 81:64\u201375.","journal-title":"Ann Hematol"},{"key":"63_CR50","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1586\/14737159.4.1.83","volume":"4","author":"A Bagg","year":"2004","unstructured":"Bagg A: Role of molecular studies in the classification of lymphoma. Expert Rev Mol Diagn 2004, 4:83\u201397.","journal-title":"Expert Rev Mol Diagn"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-004-0063-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11912-004-0063-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-004-0063-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T16:52:25Z","timestamp":1587574345000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11912-004-0063-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["63"],"URL":"https:\/\/doi.org\/10.1007\/s11912-004-0063-9","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}